Drugs / Metaderm
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03597620 | Nov 2018 → Oct 2020 | psoriasis | University of Alabama at Birmingham | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Metaderm | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03597620 ↗ |
| Route | Topical | “Metaderm cream will be applied topically twice a day to all active lesions.” NCT03597620 ↗ |